We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 5,576 results
  1. The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib

    Patients with chronic myeloid leukemia (CML) treated with nilotinib or ponatinib may experience arterial occlusive events (AOEs). It is currently...

    Olga Mulas, Elisabetta Abruzzese, ... Giovanni Caocci in Annals of Hematology
    Article Open access 28 November 2023
  2. Anticoagulants

    Anticoagulants and antithrombotic drugs are among the most frequently prescribed drugs. In the last 20 years, new drug classes have emerged, which...
    Kathrin Scherer Hofmeier in Cutaneous Drug Hypersensitivity
    Chapter 2022
  3. Purpuras

    Purpura results from coalesced petechia, which are small (≤4 mm), flat, red, discrete areas of the skin due to erythrocyte extravasation, which can...
    Torello M. Lotti, Lara Tripo, ... Mohamad Goldust in European Handbook of Dermatological Treatments
    Chapter 2023
  4. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines

    Purpose of Review

    Stroke is a leading cause of death and disability worldwide. The annual incidence of new or recurrent stroke is approximately...

    Kunal Bhatia, Lindsey M. Ladd, ... Afshin A. Divani in Current Neurology and Neuroscience Reports
    Article 11 April 2023
  5. Interferon-alpha

    Article 10 February 2024
  6. Antiplatelet and Anticoagulant Therapy in Interventional Pain Management

    Managing antithrombotic and antiplatelet therapy is one of the common issues while performing interventional techniques to balance the bleeding risk...
    Laxmaiah Manchikanti, Mahendra R. Sanapati, ... Adam M. Kaye in Essentials of Interventional Techniques in Managing Chronic Pain
    Chapter 2024
  7. Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction

    Background

    Numerous drugs have the potential to be affected by cytochrome P450 (CYP) 2B6-mediated drug–drug interactions (DDIs).

    Objectives ...
    Veronica Di Paolo, Francesco Maria Ferrari, ... Luigi Quintieri in Clinical Pharmacokinetics
    Article 20 July 2022
  8. Inhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes

    Background and Objectives

    Both AW-9A (coumarin derivative) and WES-1 (sulfonamide derivative) were designed and synthesized as potential selective...

    Fawzy A. Elbarbry, Tamer M. Ibrahim, ... Wagdy M. Eldehna in European Journal of Drug Metabolism and Pharmacokinetics
    Article 24 June 2024
  9. Clopidogrel-induced neutropenia in an 80-year-old patient with chronic kidney disease who underwent percutaneous coronary intervention: a case report and literature review

    Background

    Clopidogrel is a widely-used antiplatelet and acts as an adenosine diphosphate receptor inhibitor. Neutropenia is a rare but serious...

    Yannan Pan, Bing Liu, ... Ming Lan in BMC Cardiovascular Disorders
    Article Open access 11 February 2022
  10. Oxidative stress and its role in Fabry disease

    Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alpha-galactosidase A with consequent lysosomal...

    Martina Cacciapuoti, Giovanni Bertoldi, ... Lorenzo A. Calò in Journal of Nephrology
    Article 15 June 2024
  11. Antiplatelet and Anticoagulant Therapy in Regenerative Medicine

    Managing antithrombotic and antiplatelet therapy is one of the common issues while performing interventional techniques in regenerative medicine to...
    Laxmaiah Manchikanti, Mahendra Sanapati, ... Adam M. Kaye in Essentials of Regenerative Medicine in Interventional Pain Management
    Chapter 2024
  12. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement

    The long-term prognosis of patients with Kawasaki disease (KD) complicated by coronary artery aneurysms (CAA) is still unclear. The present,...

    Yutaro Koyama, Masaru Miura, ... Yoshihide Mitani in European Journal of Pediatrics
    Article 25 November 2022
  13. Sirolimus

    Article 20 April 2024
  14. Phenytoin

    The effect of analgesics, antibacterials, antifungal agents, antineoplastic agents, antituberculous agents, antiulcer drugs, antiviral agents,...
    Philip N. Patsalos in Antiseizure Medication Interactions
    Chapter 2022
  15. Methadone

    Methadone is an opioid with the longest elimination half life in the clinical practice of anesthesia. Traditionally used in oral form for the purpose...
    Jackson Condrey, Andrew Klein, Carey Brewbaker in First Aid Perioperative Ultrasound
    Chapter 2023
  16. Discharge of Acute Coronary Syndrome Patients on Sub-Optimal Dual Anti-Platelet Therapy: A Single Center Experience

    Purpose

    To identify and quantify the reasons why acute coronary syndrome (ACS) patients undergoing stenting at the University of New Mexico Hospital...

    Jeffrey B Booker, Alexander J Nihart, ... James C Blankenship in Cardiovascular Drugs and Therapy
    Article 10 May 2024
  17. Outcomes of patients with cerebral microbleeds undergoing percutaneous coronary intervention and dual antiplatelet therapy

    Introduction: Cerebral microbleeds (CMBs) on brain magnetic resonance imaging (MRI) are predictive of intracerebral hemorrhage (ICH). However, the...

    Masashi Fu**o, Teruo Noguchi, ... Satoshi Yasuda in Heart and Vessels
    Article 12 April 2024
  18. Thrombosis, Hemostasis, and Cardiovascular Outcomes

    Venous and arterial thromboembolism accounts for one of the highest burdens of cardiovascular morbidity and mortality. Appropriate and timely...
    Agastya D. Belur, Shengnan Zheng, ... Dinesh K. Kalra in Cardiovascular Outcomes Research
    Chapter 2024
  19. Pharmacokinetic Studies for Drug Development

    This chapter introduces investigators to the role of pharmacokinetics (PK) and toxicokinetics (TK) play in drug development. The chapter describes...
    Chapter 2023
Did you find what you were looking for? Share feedback.